ACVRL1 and acute myeloid leukemia: HHT restrains tumor progression by inhibiting some oncoproteins in various malignancies, such as EphB4 in hepatocellular carcinoma,11 PHGDH in neuroblastoma,24 and NF-κB in acute myelogenous leukemia.25